Hyperglycaemia can be modelled in in rodents with STZ, a diabetogenic drug that is toxic to insulin‐producing pancreatic β cells via the alkylation of β‐cell DNA, thus impairing insulin secretion and inducing chronic hyperglycaemia (Murtishaw et al., 2018). The gene discussed is INS; the disease is Hyperglycemia.